What smart money is saying about Medpace
5 funds in our archive have pitched Medpace — most recently Optimist Fund in September 2025.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Get an email when a fund writes about it
Position history
Between Q4 2024 and Q2 2026, 1 fund letter reported a position in Medpace, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
| Q3 2025 | 0 | 0 | 0 | 1 |
| Q2 2025 | 0 | 0 | 0 | 2 |
| Q1 2025 | 0 | 0 | 0 | 1 |
| Q4 2024 | 0 | 0 | 0 | 1 |
Fund activity · 1 position
- HoldsOptimist FundJune 2026
Listed in Optimist Fund’s reported holdings.
Read the letterMedpace
Fund coverage · 5 theses
- Optimist FundSeptember 2025
Medpace is a leading CRO that achieves consistent growth and exceptional margins by focusing on serving small and mid-sized biotech companies with a disciplined, full-service approach under the leadership of its founder-CEO.
Read the full thesis - Mairs and Power Growth FundJune 2025
Medpace Holdings is a leading contract research organization specializing in clinical trials for small and mid-sized biotech and pharmaceutical companies, positioned well in a growing market with a strong competitive advantage.
Read the full thesis - Madison Mid Cap FundJune 2025
Medpace Holdings is a rapidly growing contract research organization focused on clinical trial services for small biotech companies, led by a committed founder and with significant growth potential despite current market challenges.
Read the full thesis - VulcanMarch 2025
Medpace Holdings is a strong clinical CRO that offers full-service drug development solutions, primarily catering to small and midsized biotech firms, and is expected to return to double-digit growth after a flat year in 2025.
Read the full thesis - Giverny CapitalDecember 2024
Medpace Holdings is a leading clinical trial provider for early-stage biopharma companies
Read the full thesis
Read every full thesis on Medpace
Unlock all 5 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→